Acuren PE Ratio 2023-2025 | TIC
Current and historical p/e ratio for Acuren (TIC) from 2023 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Acuren PE ratio as of July 30, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Acuren PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2025-07-30 | 11.45 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $1.369B | $1.097B |
Acuren Corp. is engaged in providing nondestructive testing, inspection, engineering and lab testing services. It operates through following services: Nondestructive Testing, Rope Access Technician Solutions and Engineering and Lab Testing. Nondestructive Testing offerings include breadth of nondestructive testing services including conventional, advanced and tech-enabled NDT. Rope Access Technician Solutions offerings include a full suite of rope access technician offerings including inspection, repair and specialty craft service. Engineering and Lab Testing offerings include materials engineering and lab testing services. Acuren Corp. is based in Road Town, British Virgin Islands. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $222.716B | 26.12 |
Boston Scientific (BSX) | United States | $157.517B | 37.62 |
Stryker (SYK) | United States | $152.893B | 31.97 |
EssilorLuxottica (ESLOY) | France | $140.240B | 0.00 |
Medtronic (MDT) | Ireland | $118.558B | 16.81 |
Lonza Group Ag (LZAGY) | Switzerland | $50.586B | 0.00 |
Haleon (HLN) | United Kingdom | $44.070B | 25.15 |
ResMed (RMD) | United States | $40.718B | 30.58 |
GE HealthCare Technologies (GEHC) | United States | $35.587B | 16.90 |
Agilent Technologies (A) | United States | $34.042B | 22.19 |
Koninklijke Philips (PHG) | Netherlands | $26.981B | 17.85 |
Terumo (TRUMY) | Japan | $25.673B | 33.35 |
Insulet (PODD) | United States | $20.514B | 80.52 |
Zimmer Biomet Holdings (ZBH) | United States | $18.786B | 12.06 |
Baxter (BAX) | United States | $14.800B | 11.05 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.840B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
Demant (WILYY) | Denmark | $8.633B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.874B | 23.92 |
Lantheus Holdings (LNTH) | United States | $4.995B | 12.60 |
Perrigo (PRGO) | Ireland | $3.859B | 9.78 |
Prestige Consumer Healthcare (PBH) | United States | $3.689B | 16.48 |
Haemonetics (HAE) | United States | $3.629B | 16.53 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.441B | 28.59 |
ICU Medical (ICUI) | United States | $3.119B | 23.00 |
LeMaitre Vascular (LMAT) | United States | $1.863B | 41.64 |
QuidelOrtho (QDEL) | United States | $1.720B | 11.83 |
AtriCure (ATRC) | United States | $1.571B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.272B | 28.62 |
AdaptHealth (AHCO) | United States | $1.259B | 12.78 |
Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
BioLife Solutions (BLFS) | United States | $1.057B | 0.00 |
Neogen (NEOG) | United States | $1.048B | 16.66 |
Curaleaf Holdings (CURLF) | Canada | $0.933B | 0.00 |
InMode (INMD) | Israel | $0.905B | 9.11 |
Kestra Medical Technologies (KMTS) | United States | $0.847B | 0.00 |
Valneva SE (VALN) | France | $0.660B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.632B | 0.00 |
Evolus (EOLS) | United States | $0.596B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.581B | 0.00 |
Owens & Minor (OMI) | United States | $0.576B | 4.78 |
Surmodics (SRDX) | United States | $0.535B | 0.00 |
CeriBell (CBLL) | United States | $0.533B | 0.00 |
ZimVie (ZIMV) | United States | $0.524B | 23.81 |
SNDL (SNDL) | Canada | $0.384B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.322B | 11.83 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.308B | 0.00 |
Quanterix (QTRX) | United States | $0.304B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.298B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
Cerus (CERS) | United States | $0.254B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.250B | 74.00 |
Biote (BTMD) | United States | $0.249B | 7.00 |
Viemed Healthcare (VMD) | United States | $0.247B | 20.87 |
Omeros (OMER) | United States | $0.245B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
Brainsway (BWAY) | Israel | $0.224B | 59.15 |
Sanara MedTech (SMTI) | United States | $0.222B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.217B | 0.00 |
Canopy Growth (CGC) | Canada | $0.209B | 0.00 |
Organigram Global (OGI) | Canada | $0.189B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.183B | 15.09 |
Exagen (XGN) | United States | $0.180B | 0.00 |
Vireo Growth (VREOF) | United States | $0.177B | 0.00 |
High Tide (HITI) | Canada | $0.175B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.132B | 0.00 |
FitLife Brands (FTLF) | United States | $0.123B | 15.18 |
Jushi Holdings (JUSHF) | United States | $0.107B | 0.00 |
Jin Medical (ZJYL) | China | $0.100B | 0.00 |
MacroGenics (MGNX) | United States | $0.100B | 0.00 |
Fonar (FONR) | United States | $0.099B | 12.74 |
Quipt Home Medical (QIPT) | United States | $0.095B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
Safety Shot (SHOT) | United States | $0.081B | 0.00 |
Zynex (ZYXI) | United States | $0.075B | 0.00 |
Apyx Medical (APYX) | United States | $0.074B | 0.00 |
Veru (VERU) | United States | $0.072B | 0.00 |
InterCure (INCR) | Israel | $0.068B | 0.00 |
Agape ATP (ATPC) | $0.064B | 0.00 | |
ImmuCell (ICCC) | United States | $0.059B | 0.00 |
Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
Modular Medical (MODD) | United States | $0.038B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 12.92 |
Nephros (NEPH) | United States | $0.037B | 49.57 |
Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
INLIF (INLF) | $0.016B | 0.00 | |
Flora Growth (FLGC) | United States | $0.015B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
Senestech (SNES) | United States | $0.012B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
Sharps Technology (STSS) | United States | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |